An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
Open Access
- 1 November 2017
- journal article
- research article
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 10, 273-279
Abstract
Background: Usage of topical hemostatic agents in surgery is increasing, including use during minimally invasive procedures, and even for surgeries that have a low risk of bleeding complications. A novel product, Surgicel® Powder – Absorbable Hemostatic Powder (SP), made from oxidized regenerated cellulose (ORC) fabric, has been developed for adjunctive use in surgical procedures to assist in control of oozing bleeding over broad areas and where access could be difficult with a fabric ORC product. This study compares the new SP to other commercially available hemostatic powder products in two in vivo models. Methods: Hemostatic efficacy of SP was compared to two polysaccharide-based hemostats in a porcine liver punch biopsy model and to three polysaccharide-based hemostats and one non-regenerated oxidized cellulose hemostat in a porcine liver abrasion model. Primary outcomes measured were hemostatic efficacy, defined as hemostasis within 10 minutes of application, and time-to-hemostasis (TTH). Results: In the punch biopsy model, SP displayed significantly higher effective hemostasis rates than one of the polysaccharide hemostats (p=0.047) and faster TTH than both (pp≤0.002) and faster TTH (pConclusion: In both the liver punch biopsy model of mild to moderate bleeding and the liver abrasion model of mild but diffuse oozing, SP provided more effective hemostasis and faster TTH than other marketed hemostatic powders. The results from this in vivo study suggest that Surgicel Powder may be useful in clinical applications where control of oozing capillary, mild venous, and small arterial hemorrhage is required including bleeding in difficult-to-access locations.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assayJournal of Translational Medicine, 2015
- An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.2015
- Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostatsClinicoEconomics and Outcomes Research, 2015
- Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical proceduresJournal of Cardiothoracic Surgery, 2014
- Patterns of use of hemostatic agents in patients undergoing major surgeryJournal of Surgical Research, 2014
- Clinical experience with the surgicel family of absorbable hemostats (oxidized regenerated cellulose) in neurosurgical applications: a review.2013
- An Essential Primer for Understanding the Role of Topical Hemostats, Surgical Sealants, and Adhesives for Maintaining HemostasisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Effects of PerClot® on the healing of full-thickness skin wounds in ratsActa Histochemica, 2012
- Perioperative hemostasis and thrombosisCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- Surgicel®: its fate following implantationJournal of Oral Pathology & Medicine, 1984